Company page

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. (ticker: ACAD) is a publicly traded company based in the United States, with a market capitalization of approximately $4.25 billion. The company focuses on developing innovative therapies for central nervous system disorders. Acadia is committed to advancing its pipeline to address unmet medical needs in this area.